The effect of FR167653 in a canine total hepatic vascular exclusion model

Hepato-Gastroenterology

Volumn 50, Issue 49, 2003, Pages 161-164

  Sunose, Yutaka ^a   Takeyoshi, Izumi ^a   Tsutsumi, Hirofumi ^a   Kawata, Kiyoshi ^a   Iwazaki, Shigeru ^a   Matsumoto, Koshi ^b   Ohwada, Susumu ^a   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

FR167653; Interleukin 1; Ischemia reperfusion injury; Total hepatic vascular exclusion; Tumor necrosis factor

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOKINE; HYALURONIC ACID; INTERLEUKIN 1; LACTATE DEHYDROGENASE; LIVER ENZYME; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DOG; DRUG EFFECT; HISTOLOGY; ISCHEMIA; LIVER BIOPSY; LIVER BLOOD FLOW; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; HEMODYNAMIC PROCESSES; HEPATIC VENO-OCCLUSIVE DISEASE; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRCULATION; LIVER TRANSPLANTATION; PYRAZOLES; PYRIDINES; REPERFUSION INJURY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0037266604     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Cassavilla A, Ramirez C, Shapiro R, et al: Experience with liver and kidney allografts from non-heart-beating donors. Transplantation 1995; 59:197-203.
2. Ohya T, Ohwada S, Kawashima Y: The effect of hypothermic perfusion with oxygenated perfluorochemical during in situ extended hepatectomy of canine liver. J Am Coll Surg 1996; 182:219-225.
3. Kobayashi J, Takeyoshi I, Ohwada S, et al: The effects of FR167653 in extended liver resection with ischemia in dogs. Hepatology 1998; 28:459-465.
4. Takada Y, Taniguchi H, Fukunaga K, et al: Hepatic allograft procurement from non-heart-beating donors: limits of warm ischemia in porcine liver transplantation. Transplantation 1997; 63:369-373.
5. Huguet C, Addario-Chieco P, Gavelli A, Arrigo E, Harb J, Clement RR: Technique of hepatic vascular exclusion for extensive liver resection. Am J Surg 1992; 163:602-605.
6. Delva E, Camus Y, Nordinger B, et al: Vascular occlusion for liver resection. Ann Surg 1989; 209:211-218.
7. Bismuth H, Castaing D, Garden J: Major hepatic resection under total vascular exclusion. Ann Surg 1989; 210:13-19.
8. Andus T, Bauer J, Gerok W: Effects of cytokines on the liver. Hepatology 1991; 13:364-375.
9. Larrick JW, Graham D, Toy K, Lin LS, Senyk G, Fendly BM: Recombinant tumor necrosis factor causes activation of human granulocytes. Blood 1987; 69:640-644.
10. Ljungman AG, Grum CM, Deeb GM, Bolling SF, Morqanroth ML: Inhibition of cyclooxygenase metabolite production attenuates ischemia-reperfusion lung injury. Am Rev Respir Dis 1991; 143:610-617.
11. Yoshinari D, Takeyoshi Y, Koibuchi Y, et al: Effects of a dual inhibitor of tumor necrosis factor-α and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway. Crit Care Med 2001; 29:628-634.
12. Iwai M, Yamauchi T, Shimazu T: Endothelin-1 aggravates acute liver injury in perfased livers of rats after treatment with D-galactosamine. Hepatology 1998; 28:503-509.
13. Sunose Y, Takeyoshi I, Ohwada S, et al: The effect of FK 409 - a nitric oxide donor - on canine lung transplantation. J Heart Lung Transplant 2000; 19:298-309.
14. Barbotin-Larrieu F, Mazmanian M, Baudet B, et al: Prevention of ischemia reperfusion lung injury by inhaled nitric oxide in neonatal piglets. J Appl Physiol 1996; 80:782-788.
15. Suzuki S, Toledo-Pereyra LH: Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res 1994; 57:253-258.
16. Ishikawa H, Takeyoshi I, Aiba M, et al: The effective dose of FR167653 in pulmonary ischemia-reperfusion injury. Int J Surg Investig 2000; 3:243-252.
17. Yamamoto N, Sakai F, Yamazaki H, Sato N, Nakahara K, Okuhara M: FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor-α, ameliorates endotox-in-induced shock. Eur J Pharmacol 1997; 327:169-175.
18. Aiba M, Takeyoshi I, Ohwada S, et al: Optimal end point of FR167653 administration and expression of inter-leukin-8 messenger RNA on extended liver resection with ischemia in dogs. J Am Coll Surg 2000; 191:251-258.